In the present study,
S. aureus nasal colonization rate among one to 6 years old healthy children attending daycare centers in Hamadan city was 25.3%. In previous studies done by Sedighi et al. (
15,
16), in Hamedan.
S. aureus nasal colonization rate in the same population in 2008 was 29.6%, and in less than 12 years old, children in 2007 was 22.3%. Soltani et al. (
17), reported that
S. aureus nasal carrier prevalence in 1 month to 14 years old children in Kashan was 26.3%. In the Ciftci et al. (
18) survey in 2007, the prevalence of
S. aureus nasal colonization in 4 - 6 years old healthy children in Turkey was reported 28.4% and in India in 2010, 25% of healthy 1 month to 17 years old children were
S. aureus nasal carriers (
19). Therefore, the results of these studies in terms of
S. aureus nasal colonization prevalence are accordant with our results. In contrast,
S. aureus nasal colonization rate among Tanzanian children less than 5 years old was 40% and among 3 month to 6 years old Brazilian children attending daycare centers was 48%, which show a higher rate of colonization in children of those areas.
Also, 17.9% and 32.8% of HCW’s and non-HCW’s children were
S. aureus nasal carriers respectively, which was not a statistically significant difference. Shetty et al., in 2011 in India, had studied the relationship between
S. aureus colonization rate and HCW contact as a risk factor; that was not significant too (
19-
21).
In this study, methicillin, clindamycin, and vancomycin-resistant
S. aureus was only seen in one girl, whose father was a HCW. Thus resistance to these three antibiotics in children of our region is low and equal to 2.4%. Erythromycin and co-trimoxazole resistance rates were 14.7% and 8.8%, respectively. Therefore, the highest antibiotic resistance was to erythromycin (41.2% were sensitive, and 44.1% were semi sensitive). In a previous study done in Hamadan in 2008, MRSA prevalence in healthy children was 4.1%, and resistance to erythromycin was 6.8%, and there was not any vancomycin and clindamycin resistant isolates (
16). In another study done in Hamedan in 2007, CA-MRSA prevalence in less than 12 years old children was 13.7%, and resistance to erythromycin, clindamycin, and vancomycin were 33.3%, 11.1% and 0%, respectively (
15). In contrast, in Gorgan and Kashan, MRSA prevalence was 34.8%, and 35.9% and vancomycin-resistant
S. aureus (VRSA) prevalence were 1.7% and 4.3%, respectively (
18,
22). On the other hand, from 4 to 6 years old healthy children in Turkey, 0.3% had MRSA and all of them had HCW parents (
19). This rate of prevalence is obviously less than reported ranges in Iran.
D-test positiveness rate was seen in 12.1% of clindamycin sensitive isolates, which was not significantly different between the 2 groups of children. It was reported 6.8% and 37.5% in previous studies done in Hamedan (
15,
16).
In our study, there was no significant difference in
S. aureus nasal colonization between girls and boys. This is supported by some national and international studies (
18,
22,
23). However, in Sedighi et al. (
16) and some other surveys, the male gender contributed to a higher rate of colonization.
In this study,
S. aureus colonization increased significantly in older-aged children; the same result was observed with a Gorgan survey (
22). Older age was also a risk factor among children of HCWs and non-HCWs. In contrast, age less than 4 years old in Kashan and less than 6 years old in India were colonization risk factors (
17,
21). In the present study, the weight of children and their family population do not significantly affected
S. aureus colonization. However, in some studies, greater family size resulted in a higher rate of colonization (
17,
21).
History of breastfeeding did not result in a different rate of colonization, however, it was near significant (P = 0.065). However, in children of non-HCWs, it resulted in a lower rate of colonization. In our study, having smoker parents did not result in more colonization, in contrast to a survey in Kashan (
17). However, we obtained this outcome only in children of non-HCWs. It was interesting that sleeping of children next to their parents resulted in a lower range of colonization; however, it was not a risk factor. Therefore, according to the present study,
S. aureus nasal colonization rate among children attending daycare centers in Hamadan is notable and is not associated with the parent’s job. Although initial empiric treatment for staphylococcal infections depends on several factors, the most important factor is the drug resistance pattern in the community. For non-life-threatening infections like septic arthritis without signs of sepsis, if MRSA prevalence in the area is low (< 10%), anti-staphylococcal penicillin-like nafcillin, oxacillin or first-generation cephalosporins like cefazoline can be used. If MRSA prevalence in the community is high (> 10%) clindamycin can be used only if resistance to clindamycin is less than 10%; and if it is more than 10%, vancomycin should be substituted as first-line treatment (
24).
In conclusion, MRSA prevalence among children of our area is less than 10%, we therefore recommend to pediatricians of our region, to use anti-staphylococcal penicillin or first-generation cephalosporins in non-life-threatening staphylococcal infections in order to prevent antibiotic resistance and if MRSA infections are suspected. With respect to low clindamycin resistance in Hamedan (2.4%), this antibiotic can be a good choice. With respect to the mentioned issues and regarding our results, there is no difference between children of health care workers and other children. But because of the high ICR rate (12.1%), it is strongly suggested to use D-test routinely in hospital laboratories, and clindamycin be prescribed only in negative ones. We also recommend avoiding switching therapy from erythromycin to clindamycin.